Note 8 - Segment Information

3 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note

8. Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company

’s operating segments.

The Company has divided its operations into three reportable segments as follows: Contract Manufacturing,

Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the three months ended September 30, 2016 and 2015 were $2,876 and $1,992, respectively.

Financial information relating to the

three months ended September 30, 2016 and 2015 operations by business segment are as follows:

		Sales, Net			Segment
		U.S.	International		Gross		Capital
		Customers	Customers	Total	Profit	Depreciation	Expenditures
Contract Manufacturing	2016	$ 9,321	$ 2,711	$ 12,032	$ 1,897	$ 71	$ 41
	2015	6,930	1,815	8,745	1,041	59	54
Branded Proprietary Products	2016	30	95	125	34	-	-
	2015	147	172	319	128	-	-
Other Nutraceutical Businesses	2016	454	70	524	221	1	-
	2015	376	5	381	146	-	1
Total Company	2016	9,805	2,876	12,681	2,152	72	41
	2015	7,453	1,992	9,445	1,315	59	55

	Total Assets as of
	September 30,	June 30,
	2016	2016
Contract Manufacturing	$ 12,330	$ 11,853
Branded Proprietary Products	651	676
Other Nutraceutical Businesses	1,666	1,556
Total Company	$ 14,647	$ 14,085